Balyasny Asset Management LLC Edwards Lifesciences Corp Transaction History

Balyasny Asset Management LLC

$63.6 Billion
Q4 2024

A detailed history of Balyasny Asset Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 271,000 shares of EW stock, worth $19.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

271,000

Previous 12,100 2139.67%

Holding current value

$19.1 Million

Previous $798,000 2414.04%

% of portfolio

0.03%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $43.6 Million - $51.3 Million	675,651 Added 93.9%	1,395,178 $103 Million
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $17.8 Million - $27.9 Million	-297,471 Reduced 29.25%	719,527 $47.5 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $13.4 Million - $15 Million	159,291 Added 18.57%	1,016,998 $93.9 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $55.3 Million - $72.8 Million	761,969 Added 795.89%	857,707 $82 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $5.47 Million - $6.89 Million	88,577 Added 1236.94%	95,738 $7.3 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $27.1 Million - $36.5 Million	-391,177 Reduced 98.2%	7,161 $496,000
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $62 Million - $71.8 Million	-761,581 Reduced 65.66%	398,338 $37.6 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $1.83 Million - $2.08 Million	24,640 Added 2.17%	1,159,919 $96 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $77.5 Million - $99.3 Million	1,135,279 New	1,135,279 $84.7 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $66.4 Million - $79.2 Million	-645,026 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $54.1 Million - $67.6 Million	645,026 New	645,026 $66.8 Million
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $2.74 Million - $3.66 Million	-47,604 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $174,787 - $270,135	3,335 Added 7.53%	47,604 $8.98 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $3.65 Million - $4.18 Million	-50,871 Reduced 53.47%	44,269 $10.3 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $5 Million - $6.13 Million	81,218 Added 583.38%	95,140 $20.9 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $776,012 - $896,716	13,922 New	13,922 $2.57 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $5.67 Million - $7.24 Million	-152,553 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $2.68 Million - $3.13 Million	79,352 Added 108.4%	152,553 $17.2 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $2.66 Million - $2.84 Million	73,201	73,201 $8 Million

Others Institutions Holding EW

# of Institutions

1,384

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Edwards Lifesciences Corp Transaction History